首页> 外文期刊>Harm Reduction Journal >New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries
【24h】

New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries

机译:欧亚大陆的新精神活性物质:对六个国家使用毒品和伤害的人的定性研究

获取原文
           

摘要

This study examines the use of new psychoactive substances (NPS) and the harm reduction response in six Eurasian countries: Belarus, Moldova, Serbia, Kazakhstan, Kyrgyzstan, and Georgia. The aim is to identify current patterns of NPS use and related harms in each country through recording the perspectives and lived experience of people who use drugs and people who provide harm reduction services in order to inform the harm reduction response. The study involved desk-based research and semi-structured interviews/focus groups with 124 people who use drugs and 55 health and harm reduction service providers across the six countries. People who use drugs in all countries were aware of NPS, primarily synthetic cathinones and synthetic cannabinoids. NPS users generally reflected two groups: those with no prior history of illicit drug use (typically younger people) and those who used NPS on an occasional or regular basis due to the lack of availability of their preferred drug (primarily opiates). In many cases, these respondents reported they would not use NPS if traditional opiates were available. Common factors for choosing NPS included cost and accessibility. Respondents in most countries described NPS markets that use the DarkNet and social media for communication, secretive methods of payment and hidden collection points. A recurring theme was the role of punitive drug policies in driving NPS use and related harms. Respondents in all countries agreed that current harm reduction services were?important but needed to be enhanced and expanded in the context of NPS. The study identified patterns and drivers of NPS use, risk behaviours and drug-related harms. It identified gaps in the current harm reduction response, particularly the needs of non-injectors and overdose response, as well as the?harmful effects of punitive drug policies. These findings may inform and improve current harm reduction services to meet the needs of people who use NPS.
机译:本研究审查了新的精神活性物质(NPS)和六个欧亚国家的伤害响应:白俄罗斯,摩尔多瓦,塞尔维亚,哈萨克斯坦,吉尔吉斯斯坦和格鲁吉亚。目的是通过记录使用毒品和人民提供伤害减少服务的人们的人们来识别每个国家的现行使用和相关危害的现状和相关危害。该研究涉及基于桌面的研究和半结构化访谈/焦点小组,其中124人在六个国家使用毒品和55名健康和减少削减服务提供商。在所有国家使用药物的人都意识到NPS,主要是合成的天花状和合成大麻素。 NPS用户一般反映了两组:那些没有非法药物使用历史的人(通常是年轻人)以及由于缺乏其优选药物(主要是Apiates)而偶尔或定期使用NPS的人。在许多情况下,如果可以使用传统鸦片物,这些受访者报告他们不会使用NPS。用于选择NPS的常见因素包括成本和可访问性。大多数国家的受访者描述了使用Darknet和社交媒体的NPS市场进行通信,秘密付款方式和隐藏的收集点。反复出现的主题是惩罚性药物政策在驾驶NPS使用和相关危害方面的作用。所有国家的受访者都同意,目前的伤害减少服务是重要的,但在NPS的背景下需要加强和扩展。该研究确定了NPS使用的模式和驱动因素,风险行为和与毒品有关的危害。它识别目前伤害减少响应的差距,特别是非注射器的需要和过量反应,以及惩罚药物政策的有害影响。这些调查结果可以为目前的伤害减少服务提供信息,以满足使用NPS的人的需求。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号